BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15281322)

  • 1. Radiotherapy and chemotherapy for invasive bladder cancer.
    Javle M; Raghavan D
    Cancer Surv; 1998; 31():149-60. PubMed ID: 15281322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative chemotherapy in genitourinary cancer].
    Kawai K; Akaza H
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1912-7. PubMed ID: 7487120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining surgery and chemotherapy for invasive bladder cancer: current and future directions.
    Amiel GE; Lerner SP
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):281-91. PubMed ID: 16445380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant and adjuvant chemotherapy approaches for invasive bladder cancer.
    Raghavan D; Burgess E; Gaston KE; Haake MR; Riggs SB
    Semin Oncol; 2012 Oct; 39(5):588-97. PubMed ID: 23040255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
    Choueiri TK; Raghavan D
    Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review.
    Pectasides D; Pectasides M; Nikolaou M
    Eur Urol; 2005 Jul; 48(1):60-7; discussion 67-8. PubMed ID: 15967253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
    Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
    Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
    Milowsky MI; Stadler WM; Bajorin DF
    BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
    CalabrĂ² F; Sternberg CN
    Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.
    Clark PE
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):821-30. PubMed ID: 19496719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in patients with invasive bladder cancer.
    Vaughn DJ; Malkowicz SB
    Urol Clin North Am; 2005 May; 32(2):231-7. PubMed ID: 15862620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
    Izawa JI; Chin JL; Winquist E
    Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
    Sternberg CN
    Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
    Rosenberg JE
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1729-36. PubMed ID: 18062747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative chemotherapy for bladder cancer.
    Sonpavde G; Petrylak DP
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):133-44. PubMed ID: 15990329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?
    Glynne-Jones R; Hoskin P
    J Clin Oncol; 2007 Nov; 25(33):5281-6. PubMed ID: 18024876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
    Briasoulis E; Liakakos T; Dova L; Fatouros M; Tsekeris P; Roukos DH; Kappas AM
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):931-9. PubMed ID: 16761937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies.
    Garcia JA; Dreicer R
    Nat Clin Pract Urol; 2005 Jan; 2(1):32-7. PubMed ID: 16474574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.